Scientific Background

Chronic systemic disorders - spanning cardiovascular and metabolic diseases, persistent infections, neurocognitive decline, and barrier dysfunction - share convergent biochemical signatures.

These include oxidative overload, NF-κB/NLRP3–mediated inflammation, mitochondrial dysfunction, impaired methylation capacity, and endothelial uncoupling.

Despite differences in clinical presentation, these disorders stem from a common loss of network coherence among redox balance, inflammatory control, and one-carbon metabolism.

Traditional pharmacologic approaches target isolated molecules or pathways, achieving temporary suppression of symptoms but rarely restoring systemic stability.

In contrast, emerging evidence supports the nutritional pharmacology paradigm, which employs bioactive nutrients as regulatory signals that recalibrate biological networks toward homeostasis.

This systems-based approach views nutrition not as supplementation, but as signal-level modulation across interconnected molecular axes.

---

The Multi-Axis Model of Nutritional Pharmacology

The present project explores the hypothesis that chronic disease can be ameliorated through multi-axis biochemical re-synchronization, achieved by coordinating three fundamental networks:

Redox Network

Governing oxidative defense, mitochondrial energy, and adaptive resilience.

Inflammatory Network

Regulating cytokine resolution and tissue repair.

Methylation Network

Integrating genomic regulation, endothelial coupling, and neurotransmitter synthesis.

These networks form a triadic system - the Redox–Inflammatory - Methylation Tri-Axis - whose restoration underlies long-term metabolic and neurovascular stability.

Nutrients such as polyphenols, organosulfur compounds, and methylation cofactors act as biochemical synchronizers, linking antioxidant and anti-inflammatory adaptation with genomic and metabolic regulation.

---

Rationale and Objectives

The rationale of this project is to redefine the mechanistic architecture of nutritional interventions within a systems biology framework, moving from single-nutrient to multi-axis coherence strategies.

By mapping how micronutrient combinations reconstitute redox and methylation integrity, this project aims to:

• Identify molecular intersections (e.g., Nrf2–HO-1, NF-κB/NLRP3, AMPK–SIRT1–PGC-1α, BH₄–eNOS–NO, TGF-β/VEGF) that unify redox, inflammatory, and methylation processes.
• Synthesize translational evidence across metabolic, infectious, and neurocognitive disease contexts.
• Establish a quantitative systems framework - the Three-Axis, Six-Module Model - as a template for future multi-nutrient therapeutic design.

---

Scope of Disease Domains

This integrative model applies to a broad disease spectrum where systemic biochemical dysregulation is central to pathology:

- Cardio-Metabolic Axis:

Atherosclerosis, Type II Diabetes Mellitus (T2DM), Non-Alcoholic Fatty Liver Disease (NAFLD).

- Infectious and Post-Infectious Axis:

Helicobacter pylori gastritis, Post-/Long COVID–related inflammatory fatigue and endothelial dysfunction.

- Neuro-Cognitive Axis:

Cognitive decline, depressive or fatigue-related neurochemical imbalance, neurovascular coupling deficits.

- Barrier-Regeneration Axis:

Oral, gastrointestinal, and dermal epithelial repair after oxidative or microbial injury.

Across these categories, clinical data consistently demonstrate that multi-nutrient interventions - through synergistic modulation of redox, inflammatory, and methylation pathways - achieve improvements in both molecular and functional endpoints.

---

Innovation and Scientific Significance

This project provides a translational model of systems-level nutritional pharmacology, distinguished by four innovations:

• Mechanistic Depth: Integration of molecular signaling (Nrf2, AMPK, NF-κB, BH₄–eNOS) with clinically measurable biomarkers.
• Axis-Based Structure: Introduction of a multi-axis, six-module map that quantifies nutrient–signal–function relationships.
• Precision-Dose Philosophy: Focus on physiologically validated nutrient ranges that achieve signaling modulation without pharmacologic excess.
• Cross-Disease Applicability: Demonstration that restoring biochemical coherence yields therapeutic benefits across cardiovascular, hepatic, infectious, and neurocognitive systems.

Together, these innovations position the Redox–Inflammatory–Methylation Tri-Axis Model as a foundation for future research in precision nutrition, integrative medicine, and network-based therapeutics.

---

Overview of Evidence Integration

The integrative review incorporated over 80 peer-reviewed studies and meta-analyses conducted between 2015 and 2024, covering polyphenolic, organosulfur, and methylation-supportive nutrients.

Collectively, the evidence demonstrates that coordinated modulation of the redox–inflammatory–methylation triad produces clinically relevant benefits across metabolic, infectious, and neurocognitive domains.

- Oxidative and Inflammatory Markers:

Nutritional-range interventions yielded consistent reductions in malondialdehyde (MDA, −30–45%), C-reactive protein (CRP, −25–40%), interleukin-6 (IL-6, −30–45%), and tumor necrosis factor-α (TNF-α, −25–35%), confirming Nrf2 activation and NF-κB/NLRP3 suppression.

- Metabolic and Hepatic Parameters:

Across NAFLD and metabolic cohorts, garlic- and propolis-derived compounds lowered ALT and AST by 20–50%, improved lipid profiles (LDL ↓ 10–15%, triglycerides ↓ 10–20%), and normalized insulin sensitivity indices (HOMA-IR ↓ 15–25%).

- Methylation and Endothelial Function:

Folic acid and zinc supplementation (150–400 µg/day and 3–10 mg/day) reduced plasma homocysteine by 10–25% and increased flow-mediated dilation (FMD) by 15–20%, correlating with enhanced BH₄ recycling and eNOS coupling.

- Neurocognitive and Post-Infectious Outcomes:

Polyphenol–methylation synergy improved cognitive scores (MMSE ↑ 15–18%), fatigue indices in Post-/Long COVID (−42%), and mood parameters in folate-zinc co-supplementation trials (improvement ≈ 17–25%).

These results support the central hypothesis: precision-dose, multi-nutrient signaling can recalibrate systemic homeostasis without pharmacologic intensification.

---

Translational Axis Model

The findings converge on a two-dimensional network that functions as a biochemical homeostasis engine:

Axis I – Redox–Inflammatory–Metabolic/Barrier Axis

• Initiates oxidative control via Nrf2–HO-1 activation and antioxidant enzyme expression.
• Resolves inflammatory amplification through NF-κB/NLRP3 inhibition and cytokine normalization.
• Restores energy metabolism through AMPK–SIRT1–PGC-1α coupling, leading to improved mitochondrial output and lipid–glucose balance.
• Drives structural regeneration through PI3K–Akt–TGF-β/VEGF signaling in vascular and mucosal tissues.

Axis II – Methylation–Endothelial–Neuro Axis

• Reactivates one-carbon metabolism and SAM/SAH balance through folate-zinc cofactors.
• Regenerates BH₄ to stabilize eNOS coupling and enhance nitric-oxide-mediated vasodilation.
• Supports monoamine neurotransmitter synthesis (5-HT, DA, NE) via preserved BH₄-dependent hydroxylase activity.
• Reinforces neurovascular coupling and cognitive resilience through antioxidant and AMPK-driven neuro-metabolic synchronization.

The intersection of these two axes - mediated by the shared metabolic currencies NADPH, SAM, BH₄, and NO - constitutes a closed-loop feedback system that converts nutrient-level biochemical correction into cross-organ functional recovery.

---

Clinical Translation and Disease Spectrum

Applying this framework across disease categories reveals a unified intervention logic:

- Cardio-Metabolic Disorders

Redox and AMPK coupling restore vascular tone and glucose–lipid metabolism in metabolic syndrome, Type II Diabetes Mellitus, and NAFLD.

- Infectious and Post-Infectious Syndromes

Polyphenol and organosulfur nutrients modulate immune–redox balance and accelerate recovery in Helicobacter pylori and Post-/Long COVID cohorts.

- Neuro-Cognitive and Mood Disorders

Folate–zinc-supported methylation enhances neurotransmitter synthesis and neuroplasticity, mitigating cognitive decline and affective dysregulation.

- Barrier and Regenerative Pathologies

PI3K–Akt–TGF-β–VEGF activation promotes mucosal, dermal, and endothelial repair following oxidative or infectious injury.

Across these domains, physiological-range nutrient combinations demonstrate reproducible improvements in both molecular biomarkers and clinical endpoints, validating their role as systemic harmonizers rather than symptom-targeted agents.

---

Translational Implications

This project demonstrates that nutritional pharmacology can achieve signal-level reprogramming of redox, inflammatory, and methylation networks - bridging the divide between dietary modulation and pharmacologic intervention.

The framework provides:

• A model for precision-dose formulation design, ensuring biochemical synergy without toxicity.
• A clinical blueprint for adjunctive nutritional strategies in diseases characterized by multi-axis dysregulation.
• A foundation for future OSF collaborative studies linking metabolomics, transcriptomics, and clinical outcomes under a unified systems-nutrition paradigm.

---

Conclusion

The integrated evidence supports a paradigm shift from single-nutrient supplementation to multi-axis biochemical orchestration.

By synchronizing antioxidant, inflammatory, and methylation pathways within physiological limits, nutritional pharmacology attains systemic resilience and regenerative capacity that traditional monotherapies cannot replicate.

This translational model thus establishes a scientific foundation for next-generation nutritional therapeutics - anchored in molecular precision, physiological safety, and systems coherence.